SCHEMBL17290754

SCHEMBL17290754

CON=C(C)C1(NO)C(=O)N(c2ccccc2)N=C1OC

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 7/20 0.34
ALDH1A1 P00352 4/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
MEN1 O00255 5/20 0.34
KMT2A Q03164 5/20 0.34
MAPT P10636 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
POLB P06746 2/20 0.32
ATM Q13315 1/20 0.32
RECQL P46063 1/20 0.32
BLM P54132 1/20 0.32
HPGD P15428 1/20 0.31
PTGS1 P23219 2/20 0.31
KDM4E B2RXH2 1/20 0.31
CYP1A2 P05177 1/20 0.31
CHRM2 P08172 1/20 0.31
CYP3A4 P08684 1/20 0.31
CHRM1 P11229 1/20 0.31
TSHR P16473 1/20 0.31
DRD3 P35462 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17295086 1.00 GAA (0.34) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL17290753 1.00 GAA (0.34) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL17290352 0.89 KMT2A (0.35) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL17290353 0.89 KMT2A (0.35) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL17290667 0.87 SMN1; SMN2 (0.42) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL14886859 0.87 SMN1; SMN2 (0.42) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL17290507 0.84 GAA (0.33) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL17290650 0.84 LOX (0.35) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL17290510 0.84 GAA (0.33) GAAALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL17290652 0.84 LOX (0.35) GAAALDH1A1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9682938-B2 Pyrazolone derivatives as nitroxyl donors CARDIOXYL PHARMACEUTICALS, INC. (US) 2017-06-20 US claimed
US-20150344437-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS THE JOHNS HOPKINS UNIVERSITY 2015-12-03 US claimed
US-9682938-B2 Pyrazolone derivatives as nitroxyl donors CARDIOXYL PHARMACEUTICALS, INC. (US) 2017-06-20 US disclosed
EP-3148972-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS Cardioxyl Pharmaceuticals Inc. (US) 2017-04-05 EP disclosed
WO-2015183839-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS CARDIOXYL PHARMACEUTICALS, INC. (US) 2015-12-03 WO disclosed
US-20150344437-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS THE JOHNS HOPKINS UNIVERSITY 2015-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344437-A1 PYRAZOLONE DERIVATIVES AS NITROXYL DONORS TNNI3, PFKP, NOX5 GAA 1354/4885ALDH1A1 1883/4885L3MBTL1 4438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.